| Product Code: ETC7572895 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Pneumococcal Vaccine Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Pneumococcal Vaccine Market - Industry Life Cycle |
3.4 Indonesia Pneumococcal Vaccine Market - Porter's Five Forces |
3.5 Indonesia Pneumococcal Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Indonesia Pneumococcal Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Indonesia Pneumococcal Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Indonesia Pneumococcal Vaccine Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Indonesia Pneumococcal Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Pneumococcal Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases |
4.2.2 Government initiatives to improve healthcare infrastructure and increase vaccination coverage |
4.2.3 Growing prevalence of pneumococcal diseases in Indonesia |
4.3 Market Restraints |
4.3.1 High cost associated with pneumococcal vaccines, limiting affordability for some segments of the population |
4.3.2 Lack of adequate healthcare facilities in rural areas, hindering access to vaccination services |
4.3.3 Limited public health campaigns and education programs about pneumococcal diseases and vaccines |
5 Indonesia Pneumococcal Vaccine Market Trends |
6 Indonesia Pneumococcal Vaccine Market, By Types |
6.1 Indonesia Pneumococcal Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021- 2031F |
6.1.4 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021- 2031F |
6.2 Indonesia Pneumococcal Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Prevnar 13, 2021- 2031F |
6.2.3 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Synflorix, 2021- 2031F |
6.2.4 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Pneumovax 23, 2021- 2031F |
6.2.5 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Indonesia Pneumococcal Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.3 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.4 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4 Indonesia Pneumococcal Vaccine Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Indonesia Pneumococcal Vaccine Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021- 2031F |
6.5.3 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021- 2031F |
6.5.4 Indonesia Pneumococcal Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Indonesia Pneumococcal Vaccine Market Import-Export Trade Statistics |
7.1 Indonesia Pneumococcal Vaccine Market Export to Major Countries |
7.2 Indonesia Pneumococcal Vaccine Market Imports from Major Countries |
8 Indonesia Pneumococcal Vaccine Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for pneumococcal vaccine |
8.2 Number of healthcare facilities offering pneumococcal vaccination services |
8.3 Percentage of the population aware of pneumococcal diseases and the importance of vaccination |
8.4 Number of government policies or regulations supporting pneumococcal vaccination |
8.5 Number of reported cases of pneumococcal diseases in Indonesia |
9 Indonesia Pneumococcal Vaccine Market - Opportunity Assessment |
9.1 Indonesia Pneumococcal Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Indonesia Pneumococcal Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Indonesia Pneumococcal Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Indonesia Pneumococcal Vaccine Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Indonesia Pneumococcal Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Pneumococcal Vaccine Market - Competitive Landscape |
10.1 Indonesia Pneumococcal Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Pneumococcal Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here